Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, a... Reshape Lifesciences Inc is a developer of minimally invasive medical devices to treat obesity and metabolic diseases. The company's current portfolio includes the LAP-BAND, an Adjustable Gastric Banding System, the ReShape Vest, an investigational device, to help treat more patients with obesity, and ReShapeCare, a virtual coaching program delivered through an app. 詳細を表示
Revenue Increased 16.6% in the Third Quarter of 2024 Over the Second Quarter, Representing the Third Sequential Quarter of Growth, and 6.4% Compared to the Same Period in 2023 Significant...
IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences Inc. (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health-solutions company, today announced that it...
IRVINE, Calif., Nov. 12, 2024 (GLOBE NEWSWIRE) -- ReShape Lifesciences® (Nasdaq: RSLS), the premier physician-led weight loss and metabolic health solutions company, today announced that Health...
期間 † | 前日比 | 前日比 % | 始値 | 高値 | 安値 | 平均出来高 | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.25 | 5.55555555556 | 4.5 | 4.75 | 4.26 | 18575 | 4.39490269 | CS |
4 | -0.99 | -17.2473867596 | 5.74 | 5.94 | 4.09 | 29297 | 4.91697575 | CS |
12 | -0.67 | -12.3616236162 | 5.42 | 7.2 | 4.09 | 92713 | 5.61033192 | CS |
26 | -6.328 | -57.1222242282 | 11.078 | 16.5996 | 4.09 | 712132 | 10.82196669 | CS |
52 | -12.36 | -72.2384570427 | 17.11 | 29 | 4.09 | 1975522 | 13.69093349 | CS |
156 | -5737.25 | -99.9172762104 | 5742 | 5771 | 4.09 | 1515202 | 160.29053879 | CS |
260 | -748.38 | -99.369298793 | 753.13 | 27550 | 4.09 | 1427480 | 3160.3628477 | CS |
顧客サポート: +44 (0) 203 8794 460 | support@advfn.com
ADVFNのサービスをご利用いただくには、利用規約